Cameco in 3 Years: What the Energy Supercycle Could Mean for This Stock

Cameco reported 2025 revenue of $3.48 billion, up 11%, EPS of $1.35, up 246%, and Westinghouse adjusted EBITDA contribution of $219 million, up 51%. The company also strengthened its balance sheet by eliminating the remaining $200 million term loan and ending with $1.2 billion in cash versus $1 billion in total debt. Long-term contracted uranium volumes remain strong at 230 million pounds, supporting a positive outlook tied to nuclear fuel demand and Westinghouse growth.

Analysis

CCJ is not just a uranium beta; it is becoming the toll collector on the nuclear fuel cycle. The second-order winner is Westinghouse’s installed-base services and refueling economics, which should prove less volatile than spot uranium and create a valuation rerate toward infrastructure multiples rather than pure commodity multiples. That matters because if the market starts capitalizing a larger share of earnings as recurring services cash flow, the stock can keep compounding even if uranium prices merely stay elevated rather than explode.

The key competitive dynamic is that new supply cannot respond quickly enough to meaningfully cap margins over the next 12-24 months. Permitting, financing, and processing bottlenecks should keep incumbents under-earning versus the strategic value of their reserves, while long-term contracting limits downside through the cycle. The real beneficiary set also includes nuclear OEMs, engineering firms, and select industrial suppliers tied to reactor life extension and build-out, not just miners.

The main risk is that the market is front-running a multi-year thesis with a near-term multiple expansion that is vulnerable to any disappointment in reactor deployment, government funding cadence, or project execution at Westinghouse. Because the bullish case depends on long-duration capital formation, headlines can outrun fundamentals for months; a delay in U.S. reactor support or cost inflation at new builds would pressure the “infrastructure” premium quickly. In a recessionary shock, uranium demand would likely hold better than most industrial commodities, but sentiment could still compress if funding markets tighten.

The consensus may be underestimating how much of CCJ’s upside is already financed by contract coverage and balance-sheet repair, which reduces left-tail risk while preserving torque to rising replacement costs. That argues against chasing the stock outright after a strong year and toward using pullbacks or volatility to build exposure. The higher-quality expression is probably CCJ relative to more levered, earlier-cycle uranium names, because it combines scarcity value with increasingly visible cash generation.

Key Decisions for Investors

• Maintain or add to a long CCJ core position on 5-10% pullbacks; target a 12-18 month hold with downside buffered by contract coverage and net cash, upside driven by rerating toward infrastructure cash flow.
• Pair trade: long CCJ / short a higher-beta uranium developer or junior miner basket for 3-6 months to isolate the benefit of balance-sheet strength and operating scale over financing risk.
• If already long, sell upside calls against CCJ into strength over the next 1-2 months to monetize implied volatility while retaining core exposure; the thesis is multi-quarter, not a straight-line move.
• Watch Westinghouse execution as the primary catalyst/risk over the next 6-12 months; any delay or cost overrun is a signal to cut exposure by 25-50% because the valuation premium is tied to services growth.
• Use a basket long in nuclear infrastructure adjacencies rather than only miners: CCJ as anchor, with selective exposure to nuclear equipment/services names, to capture second-order spend from reactor life extension and buildout.